Uncategorized
Trump Administration Reportedly Eyes A $5,000 ‘Baby Bonus’ For New Mothers To Boost US Birthrate: ‘Sounds Like A Good Idea’ Says Trump
In an attempt to counteract the dwindling U.S. birthrate, the Trump administration is reportedly considering a variety of proposals designed to incentivize marriage and childbearing among Americans. read more
From Oil Rigs To Runways: Exxon Mobil, Boeing Get The Leveraged Trading Treatment
Direxion has launched Boeing and Exxon Mobil single-stock leveraged/inverse ETFs for traders seeking to capitalize on daily movements in headline-prone stocks. read more
Otis Raises Sales Forecast As China Drag Weighs On Elevator Giant
Otis Worldwide Corporation (NYSE:OTIS) reported lower sales and profits in its first quarter of 2025, missing analyst estimates.OTIS reports lower Q1 2025 sales and profits, missing analyst estimates. Raised net sales guidance for 2025, declares quarterly dividend increase. read more
Goldman Sachs Backs ‘Copper Tariff Trade’ If Trump Slaps 25% Duty On US Imports
Goldman Sachs predicts a 90% chance of a 25% import tariff on copper from the Trump Administration, leading to a potential arbitrage trade. read more
Want $100K Before 40? Fed Study Reveals List Of College Majors That Pay The Most
Engineering remains the top-paying field for young graduates, with most specialties earning six figures by mid-career. Passion is important, but major choice matters for salary. #engineering #salary #graduates read more
Demystifying Invesco: Insights From 19 Analyst Reviews
Latest Ratings for IVZ Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Jan 2022 Citigroup Maintains Buy Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for IVZ View the Latest Analyst Ratings read more
A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts
Latest Ratings for DGX Date Firm Action From To Feb 2022 UBS Downgrades Buy Neutral Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Wells Fargo Maintains Equal-Weight View More Analyst Ratings for DGX View the Latest Analyst Ratings read more
Forecasting The Future: 5 Analyst Projections For Arcus Biosciences
Latest Ratings for RCUS Date Firm Action From To Nov 2021 Citigroup Maintains Buy Nov 2021 Barclays Maintains Overweight Nov 2021 SVB Leerink Maintains Outperform View More Analyst Ratings for RCUS View the Latest Analyst Ratings read more
Analyst Expectations For Moodys’s Future
Latest Ratings for MCO Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 BMO Capital Maintains Outperform Mar 2022 Credit Suisse Maintains Outperform View More Analyst Ratings for MCO View the Latest Analyst Ratings read more